14158 Results (Page 264 of 567)
All Market Research Reports
Kenya Digital Therapeutics Market Analysis
Kenya Digital Therapeutics Market is at around $4 Mn in 2023 and is projected to reach $22.89 Mn in 2030, exhibiting a CAGR of 28.3 % during the forecast period. Government support, partnerships and collaborations, and the expansion of telemedicine are the factors propelling the market's growth. The market is dominated by key players like Afya Pap, Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.
Egypt Digital Therapeutics Market Analysis
Egypt Digital Therapeutics Market is at around $17 Mn in 2023 and is projected to reach $99.43 Mn in 2030, exhibiting a CAGR of 28.7 % during the forecast period. The development of healthcare infrastructure, provider acceptance, and partnerships and collaborations are driving market expansion. The market is dominated by key players like Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.
Egypt Alopecia (Hair Loss) Therapeutics Market Analysis
The Egypt Alopecia (Hair Loss) Therapeutics Market was valued at US $23 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $46 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), improved socioeconomic conditions, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Cirrus, Cipla, Lexington, and Merck, among others.
Canada Alopecia (Hair Loss) Therapeutics Market Analysis
The Canada Alopecia (Hair Loss) Therapeutics Market was valued at US $0.65 Bn in 2022, and is predicted to grow at (CAGR) of 7.50% from 2023 to 2030, to US $1.17 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of Alopecia (hair loss), improved treatment options. The industry is primarily dominated by players such as Eli Lilly, Pfizer, Allergan, Valeant, Bayer, Roche, AbbVie among others.
Brazil Alopecia (Hair Loss) Therapeutics Market Analysis
The Brazil Alopecia (Hair Loss) Therapeutics Market was valued at US $205 Mn in 2022, and is predicted to grow at (CAGR) of 8.5% from 2023 to 2030, to US $394 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), increased disposable income, lifestyle changes, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Cipla, Sun Pharmaceuticals, Theradome, and Pfizer, among others.
Japan Digital Therapeutics Market Analysis
Japan Digital Therapeutics Market is at around $0.4 Bn in 2023 and is projected to reach $2.14 Bn in 2030, exhibiting a CAGR of 27.7 % during the forecast period. The market is growing as a result of rising prevalence of chronic diseases, an aging population, and government initiatives. The market is dominated by key players like CureApp Co., Ltd., Ubie, Inc., Apple Inc., Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, and Noom Inc.
Malaysia Digital Therapeutics Market Analysis
Malaysia Digital Therapeutics Market is at around $10 Mn in 2023 and is projected to reach $57.47 Mn in 2030, exhibiting a CAGR of 27.4 % during the forecast period. Growing chronic illnesses, government programs, and technological developments are driving market growth. The market is dominated by key players like Naluri Hidup, DoctorOnCall, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., and Akili Interactive Labs.
Vietnam Allergy Therapeutics Market Analysis
Vietnam allergy therapeutics market was valued at $116 Mn in 2022 and is estimated to reach $194 Mn in 2030, exhibiting a CAGR of 6.63% during the forecast period. The demand for allergy treatment drugs is expanding due to the increased prevalence of allergic disorders and associated health problems. The top pharmaceutical companies that are currently operating in the market are GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Bayer, Pfizer, Abbott, Teva Pharmaceutical, DHG Pharma and Boston Pharmaceuticals.
Indonesia Digital Therapeutics Market Analysis
Indonesia Digital Therapeutics Market is at around $37.2 Mn in 2023 and is projected to reach $200.43 Mn in 2030, exhibiting a CAGR of 27.2 % during the forecast period. Increasing healthcare awareness, partnerships, and collaborations, investment, and funding are the drivers propelling the market's expansion. The market is dominated by key players like Halodoc, Good Doctor, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
China Digital Therapeutics Market Analysis
China Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.92 Bn in 2030, exhibiting a CAGR of 28.7 % during the forecast period. The market is expanding due to rising chronic diseases, rising healthcare awareness, and government support. The market is dominated by key players like Alibaba Health, WeDoctor, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
US Allergy Therapeutics Market Analysis
US Allergy Therapeutics Market was valued at $9744 Mn in 2022 and is estimated to reach $13751 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The market for allergy therapeutics is expanding as a result of the rising incidence of allergic illnesses and associated medical conditions. Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer are few leading companies working in the allergy therapeutics market.
UK Digital Therapeutics Market Analysis
UK Digital Therapeutics Market is at around $0.2 Bn in 2023 and is projected to reach $0.8 Bn in 2030, exhibiting a CAGR of 25.2 % during the forecast period. The healthcare system's use of digital health, technological advancements, investments, and funding are driving market expansion. The market is dominated by key players like Big Health, GAIA, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Spain Digital Therapeutics Market Analysis
Spain Digital Therapeutics Market is at around $0.12 Bn in 2023 and is projected to reach $0.61 Bn in 2030, exhibiting a CAGR of 26.2% during the forecast period. Growing Chronic diseases, government initiatives, and technological developments are propelling the growth of the market. The market is dominated by key players like Medtep, Nubentos, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
UK Allergy Therapeutics Market Analysis
UK allergy therapeutics market was valued at $603 Mn in 2022 and is estimated to reach $851 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The increasing prevalence of allergic disorders and related health problems is driving the demand for allergy therapeutics. The major pharmaceutical companies that are presently performing in the market are GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, Novartis, Pfizer, Sanofi, Merck & Co., Roche, Boehringer Ingelheim and AbbVie.
UAE Allergy Therapeutics Market Analysis
UAE allergy therapeutics market was valued at $116 Mn in 2022 and is estimated to reach $205 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The growing prevalence of allergic disorders and related medical issues is driving growth in the market for allergy treatment drugs. The top leading pharmaceutical companies operating in the market are Sanofi, GlaxoSmithKline (GSK), Novartis, Merck & Co., AstraZeneca, Bayer, Pfizer, Teva Pharmaceutical Industries, Almirall, and Chiesi Farmaceutici.
Germany Digital Therapeutics Market Analysis
Germany Digital Therapeutics Market is at around $0.23 Bn in 2023 and is projected to reach $1.12 Bn in 2030, exhibiting a CAGR of 25.4% during the forecast period. The market is being driven by an increase in chronic diseases, an aging population, and government initiatives. The market is dominated by key players like GAIA AG, Limbix Health, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
France Digital Therapeutics Market Analysis
France Digital Therapeutics Market is at around $0.17 Bn in 2023 and is projected to reach $0.9 Bn in 2030, exhibiting a CAGR of 26.2% during the forecast period. The market's expansion is being driven by government initiatives and policies, technological advancements, and an aging population. The market is dominated by key players like Mindmaze, Theravance, Voluntis, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Spain Allergy Therapeutics Market Analysis
Spain Allergy Therapeutics Market was valued at $448 Mn in 2022 and is estimated to reach $682 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period. The increasing prevalence of allergic disorders and related health problems is driving the demand for allergy therapeutics. The major pharmaceutical companies that are presently performing in the market are Novartis, GlaxoSmithKline (GSK), Sanofi, Roche, Merck & Co., Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim, and Allergan.
South Africa Allergy Therapeutics Market Analysis
South Africa Allergy Therapeutics Market was valued at $151 Mn in 2022 and is estimated to reach $272 Mn in 2030, exhibiting a CAGR of 7.63% during the forecast period. The demand for allergy treatment medications is rising due to the rise in allergic conditions and related medical conditions. GlaxoSmithKline, Sanofi, Novartis, AstraZeneca, Bayer, Aspen Pharmacare, Adcock Ingram, Lupin Ltd., Cipla Medpro, and Pfizer are the top leading pharmaceutical companies that are presently operating in the market.
Singapore Allergy Therapeutics Market Analysis
Singapore Allergy Therapeutics Market was valued at $28 Mn in 2022 and is estimated to reach $48 Mn in 2030, exhibiting a CAGR of 7% during the forecast period. The rising incidence of allergic illnesses and the resulting health issues is fueling the growing demand for allergy therapy medications. The leading pharmaceutical companies that are presently operating in the market are GlaxoSmithKline, Novartis, AstraZeneca, Merck & Co., Sanofi, Pfizer, Johnson & Johnson, Abbott, Bayer and Boehringer Ingelheim.
Mexico Digital Therapeutics Market Analysis
Mexico Digital Therapeutics Market is at around $93 Mn in 2023 and is projected to reach $508 Mn in 2030, exhibiting a CAGR of 27.45% during the forecast period. The market is propelling due to factors such as the rising prevalence of chronic diseases, the expansion of telehealth, and the rise in patient engagement and awareness. The market is dominated by key players like Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Saudi Arabia Allergy Therapeutics Market Analysis
Saudi Arabia allergy therapeutics market was valued at $394 Mn in 2022 and is estimated to reach $725 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The market for allergy therapeutics is expanding as a result of the rising incidence of allergic illnesses and associated medical conditions. Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer are few leading companies working in the allergy therapeutics market.
Canada Digital Therapeutics Market Analysis
Canada Digital Therapeutics Market is at around $0.5 Bn in 2023 and is projected to reach $2.7 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period. The industry is being driven by advancements in technology, government support and regulations, and growing awareness. The market is dominated by key players like Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., HYGIEIA, BigHealth, and Voluntis.
Saudi Arabia Digital Therapeutics Market Analysis
Saudi Arabia Digital Therapeutics Market is at around $0.11 Bn in 2023 and is projected to reach $0.62 Bn in 2030, exhibiting a CAGR of 28.7% during the forecast period. The industry is growing as a result of cultural acceptance, technological advancements, and the rising incidence of chronic diseases. The market is dominated by key players like DoctorNow, Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
UAE Digital Therapeutics Market Analysis
UAE Digital Therapeutics Market is at around $31 Mn in 2023 and is projected to reach $176.43 Mn in 2030, exhibiting a CAGR of 28.2% during the forecast period. The market is being driven by rising rates of chronic diseases, technological advancements, and rising healthcare awareness. The market is dominated by key players like Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
